title: Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma.
authors.affiliation: Gynaecologic Oncology Unit, Royal Marsden Hospital, London, U.K.
authors.forename: J R
authors.initials: JR
authors.lastname: Hardy
authors.forename: E
authors.initials: E
authors.lastname: Wiltshaw
authors.forename: P R
authors.initials: PR
authors.lastname: Blake
authors.forename: P
authors.initials: P
authors.lastname: Harper
authors.forename: M
authors.initials: M
authors.lastname: Slevin
authors.forename: T J
authors.initials: TJ
authors.lastname: Perren
authors.forename: S
authors.initials: S
authors.lastname: Tan
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005260:Female; D006402:Hematologic Diseases / Q000139:chemically induced; D006801:Humans; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D015996:Survival Rate
chemical_list: D016190:Carboplatin; D002945:Cisplatin